Topiramate

Product NDC
71610-486
11-digit product format
716100486
Labeler code
71610
Product ID
71610-486_875c3303-147e-4bdf-98f2-8355c056e18f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Topiramate
Dosage form
TABLET
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA079162
Marketing category
ANDA
Marketing start
2020-09-07
Substance
TOPIRAMATE
Active strength
50 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
0H73WJJ391TOPIRAMATE97240-79-4TOPIRAMATE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
71610-486-307161004863030 TABLET in 1 BOTTLE (71610-486-30) 30 tablet2020-12-11NoNoHistorical
71610-486-537161004865360 TABLET in 1 BOTTLE (71610-486-53) 60 tablet2021-04-07NoNoHistorical
71610-486-607161004866090 TABLET in 1 BOTTLE (71610-486-60) 90 tablet2020-11-10NoNoHistorical
71610-486-8071610048680180 TABLET in 1 BOTTLE (71610-486-80) 180 tablet2020-11-16NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
TopiramateAphena Pharma Solutions - Tennessee, LLC2021-05-03HUMAN PRESCRIPTION DRUG LABEL2